The bullet is through the church: AstraZeneca’s vaccine is approved for anyone over the age of 18.
Was it less effective for people over 65 or not: the European pharmaceutical watchdog EMA has already approved the AstraZeneca vaccine for use. The EMA itself announced this in a press release. Three vaccines have now been approved in Europe: Pfizer, Moderna and AstraZeneca.
AstraZeneca can show only 60 percent efficiency, comparable to a flu vaccine. But that’s enough, says the EMA. “With this third positive opinion, we are expanding the range of vaccines available to the EU and EEA. In this way we hope to fight the pandemic and protect our citizens, ”says Emer Cooke, the director of the EEA.
There was some fuss earlier this week when it turned out that the vaccine from AstraZeneca may not adequately protect the over-65s. “We do notice an immune response in this group, but the group tested consists largely of younger subjects”, the EMA said. In other words, the protection may be there, but that group of test subjects is not yet large enough to provide 100 percent certainty.
The approval of the AstraZeneca is also good news for our country. Even if deliveries of the vaccine do not go as expected, a complete withdrawal of AstraZeneca would severely cut vaccination planning. That in turn is bad news for the reopening of the economy.